Scholars Central

Short communicationPublished 2016

Chemogenomic Profiling: Past, Present and Beyond

Authors: Verena Pries, Dominic Hoepfner

Cellular & Molecular Medicine: Open access

Volume 2 · Issue 2 · Pages 8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Drug development of promising hits from phenotypic screens is often hampered due to a lack of information on the cellular target or the mode of action of the compound. An efficient method for target identification is chemogenomic profiling in the surrogate model Saccharomyces cerevisiae. Here we briefly review the progress of this technology, give some successful target identification examples and present future directions for haploinsufficiency and homozygous profiling in higher eukaryotes based on the CRISPR-Cas9 system.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cellular & Molecular Medicine: Open access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCellular & Molecular Medicine: Open access
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Verena Pries”
  • BylineArticles whose byline prints “Dominic Hoepfner”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels